These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 2908258
1. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria. Kollaritsch H, Stemberger H, Mailer H, Kremsner P, Kollaritsch R, Leimer R, Wiedermann G. Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258 [Abstract] [Full Text] [Related]
2. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria. de Souza JM, Sheth UK, Wernsdorfer WH, Trigg PI, Doberstyn EB. Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438 [Abstract] [Full Text] [Related]
3. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria. Reisinger EC, Horstmann RD, Dietrich M. Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482 [Abstract] [Full Text] [Related]
4. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria. Fadeke Aderounmu A, Salako LA, Laoye AJ, Modupe Makinde J, Aina Adio R. Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365 [Abstract] [Full Text] [Related]
5. Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria. Stemberger H, Leimer R, Wiedermann G. Acta Trop; 1984 Dec; 41(4):391-9. PubMed ID: 6152120 [Abstract] [Full Text] [Related]
6. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial. Bunnag D, Malikul S, Chittamas S, Chindanond D, Harinasuta T, Fernex M, Mittelholzer ML, Kristiansen S, Sturchler D. Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089 [Abstract] [Full Text] [Related]
7. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study. Salako LA, Adio RA, Walker O, Sowunmi A, Stürchler D, Mittelholzer ML, Reber-Liske R, Dickschat U. Ann Trop Med Parasitol; 1992 Dec; 86(6):575-81. PubMed ID: 1304698 [Abstract] [Full Text] [Related]
8. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria. Salako LA, Aderounmu AF, Laoye JO, Makinde JM, Adio RA. Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441 [Abstract] [Full Text] [Related]
18. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance]. Niklewski G, Landscheidt H, Glasner H. Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058 [No Abstract] [Full Text] [Related]
19. Fansimef in the treatment of malaria. Prociv P. Aust N Z J Med; 1989 Aug; 19(4):411. PubMed ID: 2675819 [No Abstract] [Full Text] [Related]
20. Clinical trial of fansimef in Indian patients of P. falciparum malaria. Asthana OP, Tangri AN, Nityanand S. Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]